Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 19(1): e0297144, 2024.
Article in English | MEDLINE | ID: mdl-38241324

ABSTRACT

Preeclampsia is a disorder that can occur during pregnancy and is one of the leading causes of death among pregnant women. This disorder occurs after the 20th week of pregnancy and is characterized by arterial hypertension, proteinuria, fetoplacental, and multiple organ dysfunctions. Despite the long history of studying preeclampsia, its etiology and pathogenesis remain poorly understood, and therapy is symptomatic. One of the factors of the disorder is believed to be misfolded proteins that are prone to form amyloid aggregates. The CRD tests, utilizing the binding of the amyloid-specific dye Congo red to urine components, demonstrate high efficiency in diagnosing preeclampsia. However, these tests have also been found to be positive in other disorders with proteinuria, presumably associated with concomitant amyloidosis. To assess the limitations of the CRD tests, we examined urine congophilia and protein components mediating Congo red positivity in patients with proteinuria, including preeclampsia, amyloid and non-amyloid nephropathies. We stained the urine samples and calculated congophilia levels. We also assessed the contribution of large protein aggregates to congophilia values using ultracentrifugation and determined the molecular weights of congophilic urinary proteins using centrifugal concentrators. All proteinuric groups demonstrate positive results in the CRD tests and congophilia levels were more than two times higher compared with the control non-proteinuric groups (p <0.01). There was a strong correlation between urine protein excretion and congophilia in amyloid nephropathy (rs = 0.76), non-amyloid nephropathies (rs = 0.90), and preeclampsia (rs = 0.90). Removal of large aggregates from urine did not affect the congophilia levels. Separation of urine protein fractions revealed congophilic components in the range of 30-100 kDa, including monomeric serum albumin. Our results indicate limitations of CRD tests in preeclampsia diagnostics in women with renal disorders and underscore the need for further research on the mechanisms of Congo red binding with urine components.


Subject(s)
Amyloidosis , Hypertension , Pre-Eclampsia , Humans , Female , Pregnancy , Pre-Eclampsia/metabolism , Congo Red , Amyloid/metabolism , Amyloidogenic Proteins , Amyloidosis/pathology , Proteinuria/diagnosis , Proteinuria/urine
2.
PLoS One ; 18(8): e0290048, 2023.
Article in English | MEDLINE | ID: mdl-37561803

ABSTRACT

Drosophila melanogaster is a popular model organism in the study of memory due to a wide arsenal of methods used to analyze neuronal activity. The most commonly used tests in research of behavioral plasticity are shock avoidance associated with chemosensory cues and courtship suppression after mating failure. Many authors emphasize the value of courtship suppression as a model of behavior most appropriate to natural conditions. However, researchers often investigate courtship suppression using immobilized and decapitated females as targets of courtship by males, which makes the data obtained from such flies less valuable. In our study, we evaluate courtship suppression towards immature mobile non-receptive females after training with mated or immature females combined with an aversive stimulus (quinine). We have shown that the previously described mechanisms of courtship suppression, as a result of the association of the courtship object with the repellent, as well as due to increased sensitivity to the anti-aphrodisiac cVA after mating failure, are not confirmed when immature mobile females are used. We discuss the reasons for the discrepancies between our results and literature data, define the conditions to be met in the courtship suppression test if the aim is to analyze the natural forms of behavioral plasticity, and present data on the test modifications to approximate conditions to natural ones.


Subject(s)
Drosophila Proteins , Drosophila melanogaster , Animals , Male , Female , Drosophila melanogaster/physiology , Drosophila Proteins/physiology , Courtship , Sexual Behavior, Animal/physiology
3.
Integr Psychol Behav Sci ; 57(1): 20-42, 2023 03.
Article in English | MEDLINE | ID: mdl-35364805

ABSTRACT

Since the middle of the 20th century, more and more data have appeared on the limited role of consciousness in determining human behavior. In this opinion paper, we hypothesize that the basis of consciousness is precisely the communicative function, and discuss relations of consciousness to other cognitive processes such sensory detection, decision-making and emotions. Within the framework of the hypothesis, consciousness is considered as a highly specialized function of the brain, which ensures encoding of personal information as communication messages. On a subjective level, mental representation just means the state of information to be shared in a human group. Accordingly, consciousness affects only those components of human behavior that are associated with the transmission of messages. Sensory detection, decision-making, emotions and other processes are only projected into consciousness during the encoding of information of them. The communication hypothesis assumes that consciousness is an adaptation that increases the efficiency of a collective way of life, and the emergence of consciousness is inextricably linked with the development of language in human culture. In the future, our view of consciousness provides an opportunity for an objective analysis of subjective phenomena by means of a directed study of the formation of messages both at the level of brain processes and at the level of interactions between individuals.


Subject(s)
Communication , Consciousness , Humans , Brain , Language , Emotions
4.
Int J Mol Sci ; 23(19)2022 Oct 01.
Article in English | MEDLINE | ID: mdl-36232958

ABSTRACT

RAD51 is a central protein of homologous recombination and DNA repair processes that maintains genome stability and ensures the accurate repair of double-stranded breaks (DSBs). In this work, we assessed amyloid properties of RAD51 in vitro and in the bacterial curli-dependent amyloid generator (C-DAG) system. Resistance to ionic detergents, staining with amyloid-specific dyes, polarized microscopy, transmission electron microscopy (TEM), X-ray diffraction and other methods were used to evaluate the properties and structure of RAD51 aggregates. The purified human RAD51 protein formed detergent-resistant aggregates in vitro that had an unbranched cross-ß fibrillar structure, which is typical for amyloids, and were stained with amyloid-specific dyes. Congo-red-stained RAD51 aggregates demonstrated birefringence under polarized light. RAD51 fibrils produced sharp circular X-ray reflections at 4.7 Å and 10 Å, demonstrating that they had a cross-ß structure. Cytoplasmic aggregates of RAD51 were observed in cell cultures overexpressing RAD51. We demonstrated that a key protein that maintains genome stability, RAD51, has amyloid properties in vitro and in the C-DAG system and discussed the possible biological relevance of this observation.


Subject(s)
Detergents , Rad51 Recombinase , Amyloid/metabolism , Amyloidogenic Proteins/chemistry , Coloring Agents , Genomic Instability , Humans , Protein Aggregates , Rad51 Recombinase/chemistry
5.
Int J Mol Sci ; 23(20)2022 Oct 21.
Article in English | MEDLINE | ID: mdl-36293523

ABSTRACT

Amyloidoses is a group of diseases characterized by the accumulation of abnormal proteins (called amyloids) in different organs and tissues. For systemic amyloidoses, the disease is related to increased levels and/or abnormal synthesis of certain proteins in the organism due to pathological processes, e.g., monoclonal gammopathy and chronic inflammation in rheumatic arthritis. Treatment of amyloidoses is focused on reducing amyloidogenic protein production and inhibition of its aggregation. Therapeutic approaches critically depend on the type of amyloidosis, which underlines the importance of early differential diagnostics. In fact, the most accurate diagnostics of amyloidosis and its type requires analysis of a biopsy specimen from the disease-affected organ. However, absence of specific symptoms of amyloidosis and the invasive nature of biomaterial sampling causes the late diagnostics of these diseases, which leads to a delayed treatment, and significantly reduces its efficacy and patient survival. The establishment of noninvasive diagnostic methods and discovery of specific amyloidosis markers are essential for disease detection and identification of its type at earlier stages, which enables timely and targeted treatment. This review focuses on current approaches to the diagnostics of amyloidoses, primarily with renal involvement, and research perspectives in order to design new specific tests for early diagnosis.


Subject(s)
Amyloidosis , Immunoglobulin Light-chain Amyloidosis , Humans , Amyloidosis/metabolism , Amyloid/metabolism , Immunoglobulin Light-chain Amyloidosis/diagnosis , Amyloidogenic Proteins , Biocompatible Materials
6.
Prion ; 15(1): 56-69, 2021 12.
Article in English | MEDLINE | ID: mdl-33910450

ABSTRACT

Alzheimer's disease (AD) is the most common form of dementia that usually occurs among older people. AD results from neuronal degeneration that leads to the cognitive impairment and death. AD is incurable, typically develops over the course of many years and is accompanied by a loss of functional autonomy, making a patient completely dependent on family members and/or healthcare workers. Critical features of AD are pathological polymerization of Aß peptide and microtubule-associated protein tau, accompanied by alterations of their conformations and resulting in accumulation of cross-ß fibrils (amyloids) in human brains. AD apparently progresses asymptomatically for years or even decades before the appearance of symptoms. Therefore, development of the early AD diagnosis at a pre-symptomatic stage is essential for potential therapies. This review is focused on current and potential molecular tools (including non-invasive methods) that are based on detection of amyloidogenic proteins and can be applicable to early diagnosis of AD.Abbreviations: Aß - amyloid-ß peptide; AßO - amyloid-ß oligomers; AD - Alzheimer's disease; ADRDA - Alzheimer's Disease and Related Disorders Association; APH1 - anterior pharynx defective 1; APP - amyloid precursor protein; BACE1 - ß-site APP-cleaving enzyme 1; BBB - brain blood barrier; CJD - Creutzfeldt-Jakob disease; CRM - certified reference material; CSF - cerebrospinal fluid; ELISA - enzyme-linked immunosorbent assay; FGD - 18F-fluorodesoxyglucose (2-deoxy-2-[18F]fluoro-D-glucose); IP-MS - immunoprecipitation-mass spectrometry assay; MCI - mild cognitive impairment; MDS - multimer detection system; MRI - magnetic resonance imaging; NIA-AA - National Institute on Ageing and Alzheimer's Association; NINCDS - National Institute of Neurological and Communicative Disorders and Stroke; PEN2 - presenilin enhancer 2; PET - positron emission tomography; PiB - Pittsburgh Compound B; PiB-SUVR - PIB standardized uptake value ratio; PMCA - Protein Misfolding Cycling Amplification; PrP - Prion Protein; P-tau - hyperphosphorylated tau protein; RMP - reference measurement procedure; RT-QuIC - real-time quaking-induced conversion; SiMoA - single-molecule array; ThT - thioflavin T; TSEs - Transmissible Spongiform Encephslopathies; T-tau - total tau protein.


Subject(s)
Alzheimer Disease , Aged , Alzheimer Disease/diagnosis , Amyloid Precursor Protein Secretases , Amyloid beta-Peptides , Amyloidogenic Proteins , Aspartic Acid Endopeptidases , Biomarkers , Humans , Positron-Emission Tomography , tau Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...